
Isolagen reports positive test results on skin-and-tissue rejuvenation product Exton, Pa. — Isolagen Inc., based here, has announced positive preliminary results from two late-stage tests of Isolagen Therapy, its skin-and-tissue rejuvenation treatment, reports the Philadelphia Business Journal. The treatment involves autologous cell therapy, the harvesting and multiplying of a patient’s own fibroblasts into tens of millions of new cells that are then injected into the patient’s skin to repair damage. The company is initially testing the therapy as a treatment for nasolabial folds. Isolagen officials say its two clinical studies produced “highly statistically significant” results in terms of decreasing the appearance of wrinkles in the skin, reports the Journal, adding that the company is preparing complete test results but would not say when the data will be made public. The company intends to file an application early next year seeking FDA approval for Isolagen Therapy. | ![]() Stay Connected to Cosmetic Surgery Times • Current Issue • Issue Archive • Subscribe to Enewsletter • Subscribe to Print Edition • Subscribe to Digital Edition • CST Radio • Events Calendar • Follow Us on Twitter Coding Counselor Simple and accurate ICD-9 code search. Start Here Formulary Counselor Find health plan drug coverage in your area. Start Here Patient Education Print customized patient education handouts. Start Here Surgical Video Center On-demand surgery demos and presentations. Start Here ![]() Featured Jobs |